Patents by Inventor Yujuan Dong

Yujuan Dong has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10900091
    Abstract: The present invention provides methods for assessing the likelihood of effectiveness of chemotherapy such as oxaliplatin treatment in colorectal cancer patients as well as their survival prospect by determining the level of miR-133a in the cancer tissue. A kit useful for such methods are also provided.
    Type: Grant
    Filed: March 22, 2019
    Date of Patent: January 26, 2021
    Assignee: The Chinese University of Hong Kong
    Inventors: Siu Man Simon Ng, Jun Yu, Joseph Jao Yiu Sung, Yujuan Dong
  • Publication number: 20200291479
    Abstract: The present invention provides methods for assessing the likelihood of effectiveness of chemotherapy such as oxaliplatin treatment in colorectal cancer patients as well as their survival prospect by determining the level of miR-133a in the cancer tissue. A kit useful for such methods are also provided.
    Type: Application
    Filed: March 22, 2019
    Publication date: September 17, 2020
    Inventors: Siu Man Simon NG, Joseph Jao Yiu Sung, Yujuan DONG
  • Patent number: 10379124
    Abstract: The present invention provides a method for diagnosing and determining prognosis of colorectal cancer in a subject by detecting suppressed expression of the VSTM2A gene, which in some cases is due to elevated methylation level in the genomic sequence of this gene. A kit and device useful for such a method are also provided. In addition, the present invention provides a method for treating colorectal cancer by increasing VSTM2A gene expression or activity.
    Type: Grant
    Filed: April 5, 2017
    Date of Patent: August 13, 2019
    Assignee: The Chinese University of Hong Kong
    Inventors: Jun Yu, Joseph Jao Yiu Sung, Simon Siu Man Ng, Yujuan Dong
  • Publication number: 20180267042
    Abstract: The present invention provides a method for diagnosing and determining prognosis of colorectal cancer in a subject by detecting suppressed expression of the VSTM2A gene, which in some cases is due to elevated methylation level in the genomic sequence of this gene. A kit and device useful for such a method are also provided. In addition, the present invention provides a method for treating colorectal cancer by increasing VSTM2A gene expression or activity.
    Type: Application
    Filed: April 5, 2017
    Publication date: September 20, 2018
    Inventors: Jun Yu, Joseph Jao Yiu Sung, Simon Siu Man Ng, Yujuan Dong